Management of Nodular Neoplasia in Barrett’s Esophagus : Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection - 20/12/17

Résumé |
Endoscopic resection has proven highly effective and safe in the removal of focal early neoplastic lesions in Barrett’s esophagus and is considered the cornerstone of endoscopic treatment. Several techniques are available for endoscopic resection in Barrett’s esophagus. The most widely used technique for piecemeal resection of early Barrett’s neoplasia is the ligate-and-cut technique. Newer techniques such as endoscopic submucosal dissection may also play a role in the treatment of neoplastic Barrett’s esophagus. Treatment of early Barrett’s neoplasia should be centralized and limited to expert centers with a high-volume load and sufficient expertise in the detection and treatment of esophageal neoplasia.
Le texte complet de cet article est disponible en PDF.Keywords : Barrett’s esophagus, High-grade dysplasia, Early cancer, Endoscopic resection, Endoscopic mucosal resection, Endoscopic submucosal dissection
Plan
Disclosures: No disclosures (K. Belghazi). Research support for IRB approved studies from GI Solutions Medtronic, Erbe Medical, C2 Therapeutic, Olympus Endoscopy, Fuji Film, Boston Scientific, Ninepoint Medical, Cernostics, Interpase, Lumen-R. Financial support for training programs from GI Solutions Medtronic, Boston Scientific. Honorarium-consultancy-speakers fee from Boston Scientific, GI Solutions Medtronic, Olympus Endoscopy, Fuji Film, WATTS-3d (J.J.G.H.M. Bergman). No disclosures (R.E. Pouw). |
Vol 27 - N° 3
P. 461-470 - juillet 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?